These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21554916)

  • 21. Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
    Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW
    J Pharmacol Exp Ther; 1991 Aug; 258(2):594-600. PubMed ID: 1907660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors.
    Reniers J; Robert S; Frederick R; Masereel B; Vincent S; Wouters J
    Bioorg Med Chem; 2011 Jan; 19(1):134-44. PubMed ID: 21183355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of MAO in MPTP toxicity--a review.
    Glover V; Gibb C; Sandler M
    J Neural Transm Suppl; 1986; 20():65-76. PubMed ID: 3091762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
    Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
    Castagnoli K; Palmer S; Castagnoli N
    Neurobiology (Bp); 1999; 7(2):135-49. PubMed ID: 10591048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases.
    Singer TP; Salach JI; Castagnoli N; Trevor A
    Biochem J; 1986 May; 235(3):785-9. PubMed ID: 3489461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone.
    Yoshihara S; Ohta S
    Arch Biochem Biophys; 1998 Dec; 360(1):93-8. PubMed ID: 9826433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neural progenitor cells are protected against MPTP by MAO-B inhibitors.
    He XJ; Uetsuka K; Nakayama H
    Neurotoxicology; 2008 Nov; 29(6):1141-6. PubMed ID: 18606181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW; Hemrick-Luecke SK; Perry KW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B.
    Fritz RR; Abell CW; Patel NT; Gessner W; Brossi A
    FEBS Lett; 1985 Jul; 186(2):224-8. PubMed ID: 3874094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and occurrence of beta-carboline alkaloids in raisins and inhibition of monoamine oxidase (MAO).
    Herraiz T
    J Agric Food Chem; 2007 Oct; 55(21):8534-40. PubMed ID: 17883257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells.
    Santillo MF; Liu Y; Ferguson M; Vohra SN; Wiesenfeld PL
    Toxicol In Vitro; 2014 Apr; 28(3):403-10. PubMed ID: 24373881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP.
    Kindt MV; Youngster SK; Sonsalla PK; Duvoisin RC; Heikkila RE
    Eur J Pharmacol; 1988 Feb; 146(2-3):313-8. PubMed ID: 3131149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons.
    McKinley ET; Baranowski TC; Blavo DO; Cato C; Doan TN; Rubinstein AL
    Brain Res Mol Brain Res; 2005 Nov; 141(2):128-37. PubMed ID: 16209898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
    Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP
    Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
    Sonsalla PK; Youngster SK; Kindt MV; Heikkila RE
    J Pharmacol Exp Ther; 1987 Sep; 242(3):850-7. PubMed ID: 2888874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Derivatives of 4-phenylpiperidine as substrates of rat brain monoamine oxidase].
    Ishkov AG; Ermakov NV; Mikerov SV; Kliatskiĭ IuIu; Miroshnichenko EV
    Vopr Med Khim; 1992; 38(2):25-8. PubMed ID: 1413624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitro.
    Corsini GU; Pintus S; Bocchetta A; Piccardi MP; Del Zompo M
    J Neural Transm Suppl; 1986; 22():55-60. PubMed ID: 3097260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B.
    Heikkila RE; Duvoisin RC; Finberg JP; Youdim MB
    Eur J Pharmacol; 1985 Oct; 116(3):313-7. PubMed ID: 3935467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.